$1.55
00.00%
At Close: -
$1.55
00.00%
After Hours: Sep 19, 9:29 AM EDT
15 minutes delayed
Milestone Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Milestone Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.14 | $-0.19 | 26.3 % |
Mar 2024 | 2024-05-13 | $-0.21 | $-0.26 | 19.2 % |
Dec 2023 | 2024-03-21 | $-0.32 | $-0.31 | -3.23 % |
Sep 2023 | 2023-11-13 | $-0.35 | $-0.38 | 7.89 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-29 | $3.50M | $870.00K | 302.3 % |
Jun 2021 | 2021-08-11 | $15.00M | $3.00M | 400.0 % |
Milestone Pharmaceuticals (MIST) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.14, which beat the estimate of $-0.19.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.